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Nitric oxide (NO) is synthesized from L-arginine by 
a group of enzymes, the nitric oxide synthases (NOS). 
Under normal circumstances the endothelial constitutive 
isoform releases small quantities of NO, which acts 
as an endogenous vasodilator and inhibits platelet 
adhesion and aggregation [l]. These actions are 
mediated by the activation of soluble guanylate cyclase 
which increases the concentration of cyclic guanosine 
monophosphate (cGMP) in target cells. Expression of 
the inducible NOS isoform is activated in various cells 
(endothelium, smooth muscle, macrophages, etc.) 
in response to inflammatory cytokines and bacterial 
lipopolysaccharide (LPS). This enzyme synthesizes 
large quantities of N O  which play a significant role 
in the characteristic hemodynamic changes of septic 
shock 111. There are indirect data supporting the idea 
of increased production of N O  during sepsis. High 
plasma and urine levels of NOz/NO3 (inactive meta- 
bolic end products of NO) have been demonstrated in 
sepsis in both animals [2] and humans [3]. Both in 
endotoxin treated rats [4] and in human septic shock 
[5], an increase in plasma cGMP levels has been 
observed. 
Keaney et al [6] have recently reported that LPS- 
induced shock in rabbits increases intraplatelet cGMP 
levels, reflecting the effect of high amounts of NO on 
these cells. Intraplatelet cGMP levels are considered to 
be a good index of the global NO pathway activity 
[1,7,8]. We hypothesized that the high production of 
NO in human sepsis should produce an increase in 
intraplatelet cGMP. We therefore measured intra- 
platelet cGMP levels in a group of septic patients and 
correlated these with other clinical and biochemical 
parameters. 
Twelve patients with sepsis (five men and seven 
women), aged 61 k 20 years (mean k standard deviation), 
were studied. Patients were eligible for study if they 
fulfilled the sepsis criteria of the American College of 
Chest Physician Society and Critical Care Medicine 
Association [9]. Table 1 shows clinical and biochemical 
parameters. Patients with acquired immunodeficiency 
syndrome, active tuberculosis, neoplasia, autoimmune 
and hematologic diseases, and patients who had 
received antiplatelet drugs, glucocorticoids, immuno- 
suppressants or antibiotics before the diagnosis, were 
excluded. The control group comprised 12 age- and 
sex-matched healthy volunteers (four men and eight 
women) aged 52 k 11 years. Informed consent was 
obtained &om all patients and volunteers and the research 
was approved by a local human investigations com- 
mittee in accordance with the Helsinki Declaration. 
Blood samples for cGMP determinations were 
collected into 0.105 M sodium citrate from the cubital 
vein, at diagnosis before starting antibiotic treatment 
(day 0), and 1 (day 1) and 7 days later (day 7). Plasma 
and intraplatelet cGMP was measured as described 
previously [7]. Serum creatinine levels were deter- 
nlined by the Jaffi- kinetic method in Autoanalyzer 
Hitachi 737 (Boehringer Mannheim, Mannheim, 
Germany). 
All data were analyzed using Statistical Package for 
Social Sciences software. Since the data distribution was 
non parametric, results are expressed as median and 
range. The Mann-Whitney rank-sum test was used 
for the comparisons between groups. Correlations 
were done with the Spearman test. Differences were 
considered significant if p < 0.05. 
As shown in Figure 1, day 0 intraplatelet cGMP 
levels were higher in the septic patients (0.87 
(0.35-5.06) pmol/109 platelets (median and range)), 
than in the control group, 0.23 (0.1-0.4) pmol/109 
platelets; p = 0.0001). Plasma cGMF’ levels were also 
significantly increased in the septic patients (4.39 
(1.59-13.78) nmol/L), when compared with the 
control group (1.87 (1.09-4.06) nmol/L, p=0.02). 
We did not find significant correlations between plasma 
or intraplatelet cGMP levels and number of platelets, 
diastolic blood pressure (DBP), systolic blood pressure 
(SBP), APACHE I1 score or serum creatinine levels at 
day 0. 
In septic patients intraplatelet cGMP levels were 
1.06 (0.19-4.80) pmol/109 platelets at day 1> and 0.58 
(0.32-2.60) pmol/109 platelets at day 7; plasma cGMP 
levels were 4.94 (2.21-1 1.96) nmol/L at day 1 and 2.82 
(2.39-6.06) nmoI/L at day 7. Intraplatelet cGMP levels 
did not change significantly after antibiotic treatment 
within the period of time studied. On the contrary, 
plasma cGMP levels of septic patients at day 7 had 
reached normal levels. 
Our study demonstrates for the first time that 
intraplatelet cGMP levels are increased in septic 
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patients, as in LPS-induced shock in rabbits [6]. Thus, 
our data suggest that in human sepsis platelets 
experience high concentrations of NO. The origin of 
this NO may be the vessel wall, the circulating 
leukocytes, or the platelets themselves [l]. High levels 
of cGMP in the platelets probably play a protective role, 
inhibiting platelet adhesion and aggregation to the 
vessels, thus preventing intravascular coagulation [ 1,2]. 
At the end of the study, intraplatelet cGMP levels 
remained elevated, suggesting that the activation of NO 
synthesis was still operative. On the other hand, all but 
one of our patients did not have septic shock, so the 
activation of the NO synthesis is probably an early 
phenomenon in sepsis. 
In agreement with other studies [4,5], we also 
found an increase in plasma cGMP levels in septic 
patients. The different time courses of plasma and 
intraplatelet cGMP levels suggest that different factors 
are responsible for these findings. In fact, it has been 
suggested that atrial natriuretic peptide (ANP) is 
responsible for the high plasma cGMP in sepsis [S]. 
Regrettably, we did not measure ANP levels in our 
patients. 
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Listeria monocytogenes septic arthritis in a natural joint: 
report of a case and review 
Clin Microbiol Infect 1998; 4: 165-168 
In non-pregnant human adults, Listeria monocytogenes 
primarily causes meningitis, encephalitis, or septicemia. 
Focal infections caused by L. rnonocytogenes are rare, and 
usually result from a primary bacteremic phase. 
We report the case of an 89-year-old male with 
dabetes mellitus and a long-standing history of bilateral 
knee arthrosis which had been periodically treated 
using non-steroidal anti-inflammatory agents. The 
patient was investigated following an increase in 
pain from the right knee plus epigastric pain. Gastro- 
duodenoscopy showed hemorrhagic fundal gastritis 
and three duodenal ulcers. A joinr. aspirate from the 
right knee revealed a serosanguineous fluid, and intra- 
articular corticosteroid injection was performed. Over 
the following 3 days, the pain increased and radiated to 
the ankle. 
The patient was then admitted to Trousseau 
Hospital, Tours, France, on 24 December 1996. 
O n  physical examination, the patient was alert and 
oriented. His temperature was 38.2”C, his pulse was 
88/min, and his blood pressure was 135/90 mmHg. 
The right knee was erythematous and warm, and had 
a marked effusion. Neurologic examination results 
were normal. Initial laboratory examination revealed 
hemoglobin 180 g/L, hematocrit 53, white blood cell 
count 10.7 X 109/L (86% polymorphonuclear leuko- 
cytes), glucose 8.50 mmol/L, and creatinine 75 pmol/L. 
A second joint aspirate was performed 3 days after the 
first, and revealed purulent fluid with a leukocyte count 
of 13.6 x 109/L (80% polymorphonnclear leukocytes). 
Gram-staining of the effusion showed Gram-positive 
rods. Culture of this fluid yielded small (3-hemolytic 
colonies which were identified as L. monocytogenes, 
serotype 4b, lysovar 1317:340. Culture of the original 
aspirate also subsequently yielded Gram-positive rods. 
Manual susceptibility testing (Kirby-Bauer disk method) 
revealed that the bacterium was susceptible to ampicillin, 
gentamicin, erythromycin, chlorarnphenicol, tetra- 
cycline, trimethoprim-sulfamethoxazole and vanco- 
mycin. Blood cultures were performed but remained 
sterile. No lumbar puncture was performed, because 
neurologic examination was normal. 
The patient was initially treated with intravenous 
amoxycillin and trimethoprim-sulfimethoxazole for 
7 days; after this, the regimen was changed to intra- 
venous amoxycillin alone. Two weeks after beginning 
antibiotic treatment, the patient had diarrhea, and 
Clostridium d@cile with toxin A was found in his 
feces. Amoxycillin treatment was terminated and 
trimethoprim-sulfamethoxazole per 0 s  was admini- 
stered (800 mg every 12 h). The patient was also treated 
with metronidazole for the following 14 days. After 
6 weeks of antibiotic treatment, the septic arthritis 
had favorably resolved. The patient reported regularly 
consuming cheese prepared from unpasteurized goats’ 
milk prior to onset of infection. 
Septic arthritis is a relatively uncommon mani- 
festation of listeriosis. A review of the English language 
